Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
34 /100
MEDIUM RISK
Score updated Oct 13, 2026

PMCB — PharmaCyte Biotech, Inc. Dilution Risk Tracker

Track PMCB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PMCB — Get alerts when the score changes →

As of October 13, 2026, PharmaCyte Biotech, Inc. (PMCB) has a DilutionWatch DilutionScore of 34/100, rated MEDIUM dilution risk. PharmaCyte Biotech, Inc. has a market capitalization of $3.92M, 10.74M shares outstanding, 32 institutional holders tracked. Stored dilution-related fields include 7.00M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
0
📊 Float Risk
27
⚠️ Warrant Exposure
90
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 46%
📜 Warrant Exercise model 60%
• Massive warrant overhang: 65% of shares outstanding
• Warrant risk score very high (90/100)
🔄 Reverse Split model est. 55%
• 50-day avg $0.75 below $1 exchange minimum
🔔 Track PMCB — Get forecast alerts →

Market Data

Market Cap$3.92M
Shares Outstanding10.74M
Float9.96M
Cash$17.84M
Debt$2.46M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore34/100DilutionWatch score record
Shares Outstanding10.74MVerified float table or market cache
Public Float9.96MVerified float table or market cache
Market Cap$3.92MMarket data cache
Cash Runway76.3 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants7.00MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 0.7% shares (2026Q1 vs prior)
32 institutional holders · 1.18M shares
#1 CITADEL ADVISORS LLC 519.7K shares
#2 GEODE CAPITAL MANAGEMENT, LLC 195.7K shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 102.9K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest133.9K
Days to Cover1.0
% of Float1.3%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-07-29
xbrl XBRL CONVERTIBLE 2025-08-11
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual PMCB Dilution Snapshot

PharmaCyte Biotech, Inc. (PMCB) has a DilutionScore of 34/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

PMCB's DilutionScore is currently 34/100 (Medium risk), with 3 score changes tracked over 89 days. The score deteriorated from 37/100 (Medium risk).

Period Score Risk Level Duration
Sep 14 – Oct 13, 202634/100MEDIUM30 days
Aug 22 – Sep 13, 202637/100MEDIUM23 days
Aug 14 – Aug 21, 202628/100MEDIUM7 days
Jul 16 – Aug 13, 202637/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

PMCB shares outstanding have increased 5.9% from 10.13M (Mar 2026) to 10.74M (Mar 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Mar 19, 202610.74M9.96M▲ 5.94%
Mar 05, 202610.13M9.40M▲ 0.46%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track PMCB Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment PMCB files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking PMCB — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PMCB
PMCB FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.